Assessment of Efficacy of KAN-JANG® in Mild COVID-19

NCT04847518 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: Kan Jang capsules
OTHER: Placebo capsules

Sponsor

Swedish Herbal Institute AB

Collaborators

[object Object]
[object Object]